Jennifer Dick, MD
Dermatology · Edina, MNNPI 1508805631
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 100.0% of the total across 11 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. It is spread thinly across 10 manufacturers, the largest accounting for just 16.8% — the pattern of someone who eats at a lot of different presentations. 2025 is the largest year on record at $78, 2.1 times the $37 reported in 2019. That places this record below the midpoint for dermatology clinicians in MN, where the typical reported total is $167.
Across 11 payments — averaging $16.16 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- LEO Pharma Inc.$30
- Regeneron Healthcare Solutions, Inc.$21
- Incyte Corporation$20
- AbbVie$19
- UCB, Inc.$16
- Galderma Laboratories, L.p.$16
- plus $57 from 4 others
What the payments were for
- Food & beverage$178100%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| LEO Pharma Inc. | 2 | $30 |
| Regeneron Healthcare Solutions, Inc. | 1 | $21 |
| Incyte Corporation | 1 | $20 |
| AbbVie | 1 | $19 |
| UCB, Inc. | 1 | $16 |
| Galderma Laboratories, L.p. | 1 | $16 |
| Sanofi | 1 | $15 |
| Biofrontera Inc. | 1 | $15 |
| Smith+Nephew | 1 | $14 |
| Helsinn Therapeutics (U.S.), Inc. | 1 | $13 |
How this compares
$178 in reported general payments places this provider in the 50th percentile of 273 dermatology providers in Minnesota.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Metronidazole | 55 | $3,089 |
| Ketoconazole | 92 | $2,018 |
| Doxycycline Hyclate | 43 | $1,741 |
| Fluocinonide | 21 | $607 |
| Fluocinolone Acetonide | 11 | $547 |
| Clobetasol Propionate | 22 | $529 |
| ValacyclovirValacyclovir Hcl | 29 | $322 |
| Triamcinolone Acetonide | 43 | $304 |
Paid to pharmacies, not to this prescriber.
Other dermatology in Edina
- Mimi ChoEdina$2K
- Marie BridenEdina$2K
- Arthur IdeEdina$1K
- Michelle BussmannEdina$1K
- Kristina ShafferEagan$538K
- Margareth Pierre-LouisMinneapolis$439K
- Maria HordinskyMinneapolis$85K
- Afsaneh AlaviRochester$71K
- Todd SeelhammerSaint Paul$63K
- Brittney SchultzMinneapolis$52K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.